Epigenetic alterations in creatine transporter deficiency: a new marker for dodecyl creatine ester therapeutic efficacy monitoring
Creatine transporter deficiency (CTD) is an X-linked disease caused by mutations in the Slc6a8 gene. The impaired creatine uptake in the brain leads to developmental delays with intellectual disability. We hypothesized that deficient creatine uptake in CTD cerebral cells impact methylation balance l...
Main Authors: | Léa Broca-Brisson, Clémence Disdier, Rania Harati, Rifat Hamoudi, Aloïse Mabondzo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-04-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2024.1362497/full |
Similar Items
-
Dodecyl creatine ester improves cognitive function and identifies key protein drivers including KIF1A and PLCB1 in a mouse model of creatine transporter deficiency
by: Aloïse Mabondzo, et al.
Published: (2023-03-01) -
Molecular Heterogeneity of the Brain Endothelium
by: Nada Alnaqbi, et al.
Published: (2023-04-01) -
Creatine and creatine kinase in health and disease [electronic resource]: /
by: Salomons, Gajja S., et al.
Published: (2007) -
miR-27a-3p regulates expression of intercellular junctions at the brain endothelium and controls the endothelial barrier permeability.
by: Rania Harati, et al.
Published: (2022-01-01) -
Exosomes Interactions with the Blood–Brain Barrier: Implications for Cerebral Disorders and Therapeutics
by: Zaynab Osaid, et al.
Published: (2023-10-01)